DK46787A - Antiviralt middel - Google Patents

Antiviralt middel

Info

Publication number
DK46787A
DK46787A DK046787A DK46787A DK46787A DK 46787 A DK46787 A DK 46787A DK 046787 A DK046787 A DK 046787A DK 46787 A DK46787 A DK 46787A DK 46787 A DK46787 A DK 46787A
Authority
DK
Denmark
Prior art keywords
antiviral agent
combinations
nucleoside
inhibitors
converted
Prior art date
Application number
DK046787A
Other languages
English (en)
Other versions
DK46787D0 (da
Inventor
Thomas Paul Zimmerman
Gerald Wolberg
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK46787D0 publication Critical patent/DK46787D0/da
Publication of DK46787A publication Critical patent/DK46787A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DK046787A 1986-01-30 1987-01-29 Antiviralt middel DK46787A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868602346A GB8602346D0 (en) 1986-01-30 1986-01-30 Antiviral combinations

Publications (2)

Publication Number Publication Date
DK46787D0 DK46787D0 (da) 1987-01-29
DK46787A true DK46787A (da) 1987-07-31

Family

ID=10592262

Family Applications (1)

Application Number Title Priority Date Filing Date
DK046787A DK46787A (da) 1986-01-30 1987-01-29 Antiviralt middel

Country Status (20)

Country Link
US (1) US4897394A (da)
EP (1) EP0235931B1 (da)
JP (1) JPS62195337A (da)
KR (1) KR870006900A (da)
AT (1) ATE54414T1 (da)
AU (1) AU590817B2 (da)
CA (1) CA1283361C (da)
DD (1) DD261095A5 (da)
DE (1) DE3763597D1 (da)
DK (1) DK46787A (da)
ES (1) ES2031883T3 (da)
FI (1) FI870377A (da)
GB (1) GB8602346D0 (da)
GR (1) GR3000638T3 (da)
HU (1) HU198394B (da)
IL (1) IL81422A0 (da)
MC (1) MC1791A1 (da)
PL (1) PL263871A1 (da)
PT (1) PT84219B (da)
ZA (1) ZA87667B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4782065A (en) * 1984-04-18 1988-11-01 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US4800081A (en) * 1984-04-18 1989-01-24 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US4849412A (en) * 1986-06-05 1989-07-18 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US5879700A (en) * 1991-10-15 1999-03-09 Hostetler; Karl Y. Nucleoside analogue phosphates for topical use
US5580571A (en) * 1991-10-15 1996-12-03 Hostetler; Karl Y. Nucleoside analogues
WO1994018979A2 (en) * 1993-02-19 1994-09-01 Southern Research Institute Methods of treatment of viral infections using carbocyclic deoxyguanosine analogs
AU6516494A (en) * 1993-04-15 1994-11-08 New York University Adenosine receptor agonists for the promotion of wound healing
US5654286A (en) * 1993-05-12 1997-08-05 Hostetler; Karl Y. Nucleotides for topical treatment of psoriasis, and methods for using same
US6015573A (en) * 1993-05-12 2000-01-18 Hostetler; Karl Y. Nucleoside phosphate therapy for viral infection
EP0746319A4 (en) * 1993-05-12 1997-11-05 Karl Y Hostetler ACYCLOVIR DERIVATIVES FOR TOPICAL USE
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US5677308A (en) * 1996-12-19 1997-10-14 Lerner; A. Martin Method for alleviating spasmodic torticollis
US6537997B1 (en) 1997-02-18 2003-03-25 A. Martin Lerner Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US5872123A (en) 1997-02-18 1999-02-16 Lerner; A. Martin Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US6399622B1 (en) 1997-02-18 2002-06-04 A. Martin Lerner Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
NZ532944A (en) * 2001-10-16 2005-10-28 Avanir Pharmaceuticals Stable, topical formulation for treating viral and inflammatory conditions comprising 10% n-docosanol, 5% of a stearate, 8% mineral oil, 5% propylene glycol, 2.7% benzyl alcohol and water
WO2013023362A1 (zh) * 2011-08-16 2013-02-21 深圳市卫武光明生物制品有限公司 静注巨细胞病毒人免疫球蛋白及其制备方法
US20140100238A1 (en) 2012-10-04 2014-04-10 Ohio State University Method of diagnosing and treating epstein barr virus-based myalgic encephalomyelitis chronic fatigue syndrome patients
CN105079404A (zh) * 2015-09-07 2015-11-25 夏云强 一种治疗多重耐药菌所致感染性创面的中药外洗剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
ZW22283A1 (en) * 1982-10-14 1985-05-22 Wellcome Found Antiviral compounds
GB8320308D0 (en) * 1983-07-28 1983-09-01 Wellcome Found Antiviral combinations
DK224286A (da) * 1985-05-15 1986-11-16 Wellcome Found 2',3'-dideoxy-nucleosider
DE3627024A1 (de) * 1985-09-24 1987-04-02 Hoechst Ag In 6- und 9-stellung substituierte 2-aminopurine, ihre verwendung, diese purine enthaltende arzneimittel und verfahren zur herstellung der purine
MY101126A (en) * 1985-12-13 1991-07-31 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
MC1791A1 (fr) 1987-10-22
HUT42941A (en) 1987-09-28
ATE54414T1 (de) 1990-07-15
FI870377A (fi) 1987-07-31
US4897394A (en) 1990-01-30
ZA87667B (en) 1988-09-28
DD261095A5 (de) 1988-10-19
AU6813587A (en) 1987-08-06
KR870006900A (ko) 1987-08-13
EP0235931A1 (en) 1987-09-09
FI870377A0 (fi) 1987-01-29
ES2031883T3 (es) 1993-01-01
JPS62195337A (ja) 1987-08-28
EP0235931B1 (en) 1990-07-11
PL263871A1 (en) 1988-05-12
AU590817B2 (en) 1989-11-16
HU198394B (en) 1989-10-30
GR3000638T3 (en) 1991-09-27
PT84219B (pt) 1989-07-31
IL81422A0 (en) 1987-08-31
PT84219A (en) 1987-02-01
GB8602346D0 (en) 1986-03-05
DK46787D0 (da) 1987-01-29
DE3763597D1 (de) 1990-08-16
CA1283361C (en) 1991-04-23

Similar Documents

Publication Publication Date Title
DK46787D0 (da) Antiviralt middel
EP0135713A3 (en) Antiviral combinations
PT100199A (pt) Combinacao antiviral de nucleosidos e processo para a sua preparacao
DE3854297D1 (de) Nucleoside und nucleotide mit antiviraler, antitumoraler, antimetastatischer sowie immunstimulierender wirkung.
SE8405133D0 (sv) Anti-viralt medel
EA200300819A1 (ru) Производные нуклеозидов в качестве ингибиторов рнк-зависимой рнк вирусной полимеразы
PT741577E (pt) Utilizacao do subtipo de interferao alfa 8 na preparacao de medicamentos para tratar infeccoes virais do figado
ATE108066T1 (de) Topisch aktive doppelstrang-rns- zusammensetzungen.
ATE376445T1 (de) Synergistische hemmung von viralreplikation durch langkettigen kohlenwasserstoffe und nucleosid- analoge
ATE170846T1 (de) Antivirale nukleosidanaloge
CA2380924A1 (en) Compositions for treating viral infections, and methods therefor
DK615788A (da) Nucleosidforbindelser til anvendelse mod virale infektioner
TR200102024T2 (tr) Yeni tedavi.
IT8423517A0 (it) Composizione farmaceutica per combattere infezioni virali, eprocedimento di uso per le infezioni virali.
ATE72122T1 (de) Antivirale mischungen.
FR2621816B1 (fr) Application antivirale des ologonucleotides
KR920019362A (ko) 디데옥시 아데노신 및 아데노신 데아미나제 억제물질을 포함하는, 항-hiv활성을 지닌 치료학적 조성물
DE3687895D1 (de) Arginin- und agmatinderivate zur behandlung von protozoen-infektionen.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment